Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Active, not recruiting	Phase 3	2026-07-24		NCT04776655

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda USL Reggio Emilia - IRCCS	45
Istituto Di Ricerche Farmacologiche Mario Negri	13
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale	16

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AUSL/IRCCS di Reggio Emilia	Reggio Emilia	Italy	1
Azienda Ulss 3 Serenissima	Mirano	Italy	2
Ospedale Civile di Guastalla	Guastalla	Italy	1
Ospedale San Salvatore	Coppito	Italy	1